In terms of TS management, especially for growth hormone treatment, these data had clinical importance, because growth response is negatively correlated with age at the start of therapy [22,23] and similar to girls with TS, X/XY children with short stature also benefit from growth hormone treatment, especially when it initiates early [23]. The gene discussed is GH1; the disease is Timothy syndrome.